全文获取类型
收费全文 | 2274篇 |
免费 | 178篇 |
国内免费 | 1篇 |
出版年
2023年 | 8篇 |
2022年 | 8篇 |
2021年 | 20篇 |
2020年 | 20篇 |
2019年 | 29篇 |
2018年 | 28篇 |
2017年 | 22篇 |
2016年 | 53篇 |
2015年 | 125篇 |
2014年 | 153篇 |
2013年 | 177篇 |
2012年 | 193篇 |
2011年 | 191篇 |
2010年 | 110篇 |
2009年 | 105篇 |
2008年 | 127篇 |
2007年 | 118篇 |
2006年 | 109篇 |
2005年 | 105篇 |
2004年 | 99篇 |
2003年 | 71篇 |
2002年 | 70篇 |
2001年 | 66篇 |
2000年 | 56篇 |
1999年 | 47篇 |
1998年 | 24篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 11篇 |
1994年 | 13篇 |
1993年 | 7篇 |
1992年 | 26篇 |
1991年 | 37篇 |
1990年 | 24篇 |
1989年 | 16篇 |
1988年 | 19篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1983年 | 5篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1971年 | 4篇 |
1969年 | 5篇 |
排序方式: 共有2453条查询结果,搜索用时 15 毫秒
1.
En-Chi Chiu Shu-Chun Lee Chian-Jue Kuo For-Wey Lung I-Ping Hsueh Ching-Lin Hsieh 《PloS one》2015,10(11)
A performance-based measure for assessing executive functions (EF) is useful to understand patients’ real life performance of EF. This study aimed to develop a performance-based measure of executive functions (PEF) based on the Lezak model and to examine psychometric properties (i.e., unidimensionality and reliability) of the PEF using Rasch analysis in patients with schizophrenia. We developed the PEF in three phases: (1) designing the preliminary version of PEF; (2) consultation with experts, cognitive interviews with patients, and pilot tests on patients to revise the preliminary PEF; (3) establishment of the final version of the PEF and examination of unidimensionality and Rasch reliability. Two hundred patients were assessed using the revised PEF. After deleting items which did not satisfy the Rasch model’s expectations, the final version of the PEF contained 1 practice item and 13 test items for assessing the four domains of EF (i.e., volition, planning, purposive action, and effective performance). For unidimensional and multidimensional Rasch analyses, the 4 domains showed good reliability (i.e., 0.77–0.85 and 0.87–0.90, respectively). Our results showed that the PEF had satisfactory unidimensionality and Rasch reliability. Therefore, clinicians and researchers could use the PEF to assess the four domains of EF in patients with schizophrenia. 相似文献
2.
Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes 总被引:17,自引:0,他引:17
R M Gerstein W N Frankel C L Hsieh J M Durdik S Rath J M Coffin A Nisonoff E Selsing 《Cell》1990,63(3):537-548
Transgenic mice carrying an immunoglobulin mu heavy chain transgene exhibit isotype switching of the transgene. We have now characterized the mechanism of transgene switching in these mice. The site of mu transgene insertion in one transgenic line has been localized to chromosome 5 using a series of polymorphic endogenous retroviruses as genetic markers in backcross mice. The endogenous immunoglobulin heavy chain locus resides on mouse chromosome 12, which shows that transgene isotype switching can occur between two different chromosomes even though normal antibody gene switching has generally been thought to occur within one chromosome. We find that transgene isotype switching involves interchromosomal DNA recombination, and our data suggest that the same enzymatic mechanisms mediate both normal isotype switch recombination and interchromosomal transgene switching. Our findings also support the notion that the isotype switching mechanism can induce chromosomal translocations such as observed for the c-myc gene in some B cell tumors. 相似文献
3.
Carrier detection and prenatal diagnosis of alpha-thalassemia of Southeast Asian deletion by polymerase chain reaction 总被引:7,自引:0,他引:7
Summary Alpha-thalassemia of Southeast Asian deletion (-- SEA/) is very common in Southeast Asia. Homozygosity of this genotype is the major cause of Hb Bart's hydrops fetalis in Taiwan. With polymerase chain reaction using three oligonucleotide primers bridging the common deletion breakpoint, a DNA fragment of 194 basepairs (bp) was amplified in chromosomes with the-- SEA determinant and a DNA fragment of 287 bp was amplified in chromosomes without this deletion. In our pilot study including 8 normal subjects, 20 obligate carriers, and 11 homozygotes of the deletion, all the genotypes were determined and then confirmed by Southern blotting and DNA hybridization with globin gene probe. For prenatal diagnosis, 55 at-risk pregnancies were collected. Chorionic villus sampling was done in 51 cases and early amniocentesis was done in 4 cases. Fourteen cases (25.5%) were diagnosed as normal, 25 (45.5%) as heterozygotes, and 16 (29%) as homozygotes of -- SEA. All of the diagnoses were also confirmed as aforementioned. With polymerase chain reaction, the determination of the -- SEA deletion is straightforward and is much quicker and easier than with conventional Southern blotting and DNA hybridization. In areas with a high prevalence of -- SEA deletion, this method provides a rapid tool for carrier detection and prenatal diagnosis. 相似文献
4.
5.
Four coumaronochromones, formosanatins A–D (Fig. 1 and Fig. 2–4), and a flavanone, euchrenone a16 (Fig. 1 and Fig. 2), along with four known compounds, euchretins E and G, euchrestaflavanone A, and daidzein, were isolated from the roots of Euchresta formosana. The structures of Fig. 1 and Fig. 2– Fig. 1 and Fig. 2 were established by spectroscopic analyses. 相似文献
6.
A proteomics approach to identifying novel protein targets involved in erinacine A–mediated inhibition of colorectal cancer cells’ aggressiveness 下载免费PDF全文
Ko‐Chao Lee Hsing‐Chun Kuo Chien‐Heng Shen Chien‐Chang Lu Wen‐Shih Huang Meng‐Chiao Hsieh Cheng‐Yi Huang Yi‐Hung Kuo Yung‐Yu Hsieh Chih‐Chuan Teng Li‐Ya Lee Shui‐Yi Tung 《Journal of cellular and molecular medicine》2017,21(3):588-599
Erinacine A, a major active component of a diterpenoid derivative isolated from Hericium erinaceus mycelium, has been demonstrated to exert anticancer effects. Herein, we present an investigation of the molecular mechanism of erinacine A induction associated with cancer cells’ aggressive status and death. A proteomic approach was used to purify and identify the differentially expressed proteins following erinacine A treatment and the mechanism of its action in apoptotic and the targets of erinacine A. Our results demonstrate that erinacine A treatment of HCT‐116 and DLD‐1 cells increased cell cytotoxicity and reactive oxygen species (ROS) production as well as decreased cell proliferation and invasiveness. Ten differentially displayed proteins were determined and validated in vitro and in vivo between the erinacine A‐treated and untreated groups. In addition, erinacine A time‐dependent induction of cell death and inhibitory invasiveness was associated with sustained phosphorylation of the PI3K/mTOR/p70S6K and ROCK1/LIMK2/Cofilin pathways. Furthermore, we demonstrated that erinacine A–induced HCT‐116 and DLD‐1 cells viability and anti‐invasion properties by up‐regulating the activation of PI3K/mTOR/p70S6K and production of ROS. Experiments involving specific inhibitors demonstrated that the differential expression of cofilin‐1 (COFL1) and profilin‐1 (PROF1) during erinacine A treatment could be involved in the mechanisms of HCT‐116 and DLD‐1 cells death and decreased aggressiveness, which occurred via ROCK1/LIMK2/Cofilin expression, with activation of the PI3K/mTOR/p70S6K signalling pathway. These findings elucidate the mechanism of erinacine A inhibiting the aggressive status of cells by activating PI3K/mTOR/p70S6K downstream signalling and the novel protein targets COF1 and PROF1; this could be a good molecular strategy to limit the aggressiveness of CRC cells. 相似文献
7.
8.
Ming-Lun Yeh Cheng-Yuan Peng Chia-Yen Dai Hsueh-Chou Lai Chung-Feng Huang Ming-Yen Hsieh Jee-Fu Huang Shinn-Cherng Chen Zu-Yau Lin Ming-Lung Yu Wan-Long Chuang 《PloS one》2015,10(4)
Background
Studies are limited on pegylated interferon (Peg-IFN) therapy for chronic hepatitis B (CHB) patients who failed or relapsed on previous antiviral therapy.Objectives
We aimed to investigate the effect of Peg-IFN therapy in treatment-experienced CHB patients.Study Design
A total of 57 treatment-experienced CHB patients at two medical centers were enrolled. All of the patients were treated with Peg-IFN α-2a at 180 μg weekly for 24 or 48 weeks. The hepatitis B serological markers and viral loads were tested every 3 months until 1 year after stopping Peg-IFN therapy. The endpoints were HBV DNA <2000IU/mL, hepatitis B e antigen (HBeAg) seroconversion, and a hepatitis B surface antigen (HBsAg) loss at 12 months post-treatment.Results
In HBeAg-positive patients, 25.0%, 29.2%, and 12.5% of the patients achieved HBeAg seroconversion, HBV DNA <2000 IU/mL and a combined response, respectively, at 12 months post-treatment. Prior IFN therapy, a high baseline ALT level, a low creatinine level, undetectable HBV DNA at 12 weeks and a decline in HBV DNA >2 log10 IU/mL at 12 weeks of therapy were factors associated with treatment response. In HBeAg-negative patients, 9.1%, 15.2%, and 6.1% of the patients achieved undetectable HBV DNA, HBV DNA <2000 IU/mL, and an HBsAg loss, respectively, at 12 months post-treatment. No factor was significantly associated with the treatment response in the HBeAg-negative patients. The median HBsAg level declined from 3.4 to 2.6 log10 IU/mL in all the patients, and the 5-year cumulative rate of the HBsAg loss was 9.8% in the HBeAg-negative patients. Overall, none of the patients prematurely discontinued the Peg-IFN therapy.Conclusions
Peg-IFN re-treatment is effective for a proportion of HBeAg-positive treatment-experienced patients; it has limited efficacy for HBeAg-negative treatment-experienced patients. Peg-IFN might facilitate HBsAg loss in HBeAg-negative treatment-experienced patients. 相似文献9.
Of 25 commercial lipases, nine were able to catalyse the hydrolysis of ethyl D,L-2-amino-4-phenylbutyrate (D,L-APBAE) to optically active D-APBAE, an intermediate for the synthesis of inhibitors of angiotensin-converting enzyme, with specific selectivity ranging between 3.7 and 12.5. Optimal conditions for porcine pancrease lipase-catalyzed reaction gave a 68% conversion and the D-ester was obtained by a simple extraction with an optical purity of 98%. Saponification of the ethyl ester of D-APBA in 1 M NaOH gave the optically active D-APBA with a chemical purity greater than 99%. 相似文献
10.
Ya-Hsu Yang Hao-Wei Teng Yen-Ting Lai Szu-Yuan Li Chih-Ching Lin Albert C. Yang Hsiang-Lin Chan Yi-Hsuan Hsieh Chiao-Fan Lin Fu-Ying Hsu Chih-Kuang Liu Wen-Sheng Liu 《PloS one》2015,10(9)